State laws bypass research ban
By Christian Science Monitor,
Christian Science Monitor
| 02. 01. 2006
Washington has effectively put a lid on federal efforts to advance embryonic stem-cell research. But pressure from scientists eager to expand their knowledge, special interest groups searching for new cures for diseases, and those who see a lucrative new biomedical industry has found a relief valve: the nation's 50 statehouses.
Stem-cell initiatives flowing from legislatures and governors' offices continue to gather steam, including some that permit controversial human cloning to generate embryonic stem cells. In response, opponents of such research, who find it ethically unacceptable, have also stepped up their activity in states - with some success.
There has been an "explosion" of state activity since 2000-01, says Alissa Johnson, who tracks genetics issues for the National Conference of State Legislatures (NCSL). An August 2001 Bush administration mandate to restrict embryonic stem-cell research to a few existing stem-cell lines has "created a state-by-state [stem-cell] movement unprecedented in medical research," wrote Paul Sanberg, director of the Center for Aging and Brain Repair at the University of South Florida, Tampa, in October's issue of The Scientist.
In 2005, states considered at least...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...